To further evaluate the role of CD44 on the P-gp-induced drug resistant phenotype, and to determine whether P-gp was functional, the cytotoxicity of doxorubicin, a known substrate of P-gp, was analyzed in breast cancer cells (Figure 3F). Here, CD44 is linked to breast cancer.